Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.
Flieswasser T; Van den Eynde A; Freire Boullosa L; Melis J; Hermans C; Merlin C; Lau HW; Van Audenaerde J; Lardon F; Smits E; Pauwels P; Jacobs J.
Oncoimmunology
(Unknown)
Published: 2023
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer.
Oncoimmunology
(Unknown)
Published: 2023
Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALL.
Ziegler N; Cortés-López M; Alt F; Sprang M; Ustjanzew A; Lehmann N; El Malki K; Wingerter A; Russo A; Beck O; Attig S; Roth L; König J; Paret C; Faber J.
Oncoimmunology
(Unknown)
Published: 2023
BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells …
Esteso G; Felgueres MJ; García-Jiménez ÁF; Reyburn-Valés C; Benguría A; Vázquez E; Reyburn HT; Aguiló N; Martín C; Puentes E; Murillo I; Rodríguez E; Valés-Gómez M.
Oncoimmunology
(Unknown)
Published: 2022
Cellular senescence enhances adaptive anticancer immunosurveillance.
Oncoimmunology
(Unknown)
Published: 2022
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8<sup>+</sup> T cells eradicates peritoneal m…
Di Trani CA; Cirella A; Arrizabalaga L; Bella Á; Fernandez-Sendin M; Russo-Cabrera JS; Gomar C; Olivera I; Bolaños E; González-Gomariz J; Álvarez M; Etxeberria I; Palencia B; Teijeira Á; Melero I; Berraondo P; Aranda F.
Oncoimmunology
(Unknown)
Published: 2022
BCL11B depletion induces the development of highly cytotoxic innate T cells out of IL-15 stimulated peripheral blood αβ…
Forkel H; Grabarczyk P; Depke M; Troschke-Meurer S; Simm S; Hammer E; Michalik S; Hentschker C; Corleis B; Loyal L; Zumpe M; Siebert N; Dorhoi A; Thiel A; Lode H; Völker U; Schmidt CA.
Oncoimmunology
(Unknown)
Published: 2022
Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells.
Werchau N; Kotter B; Criado-Moronati E; Gosselink A; Cordes N; Lock D; Lennartz S; Kolbe C; Winter N; Teppert K; Engert F; Webster B; Mittelstaet J; Schaefer D; Mallmann P; Mallmann MR; Ratiu D; Assenmacher M; Schaser T; von Bergwelt-Baildon M; Abramowski P; Kaiser AD.
Oncoimmunology
(Unknown)
Published: 2022